FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to laboratory diagnostics, and is intended to quantify the effectiveness of antibacterial drugs and new chemical compounds against the conditionally pathogenic species Pseudomonas aeruginosa.
EFFECT: invention increases the accuracy of assessment and reduces study duration.
1 cl, 2 dwg, 2 ex
Authors
Dates
2021-11-30—Published
2021-05-17—Filed